Company Filing History:
1 out of 2 
1 out of 1 
1 out of 91 
Years Active: 2015-2016
Title: Uta Behrends: Innovator in Immunology
Introduction
Uta Behrends is a distinguished inventor based in Munich, Germany, known for her valuable contributions to the field of immunology. With two patents to her name, she has made significant advancements in identifying and utilizing CD4+ T cell antigens, demonstrating a strong focus on improving medical applications that can benefit patients with specific health challenges.
Latest Patents
Among her latest patents, the first titled "Method of Identifying CD4+ T Cell Antigens" focuses on a novel methodology for identifying antigens linked with CD4+ T cells. This innovative method not only addresses the identification process but also supports the application of the identified antigens in medical settings.
Her second patent, "Ex Vivo Method for Producing a Preparation Containing CD4+ T Cells Specific for EBV Structural Antigens," presents a groundbreaking approach to producing CD4+ T cell preparations targeted at EBV structural antigens. This method is designed for the prophylaxis and treatment of individuals with compromised T cell activity, aiming to counteract the growth of EBV-infected B cells effectively.
Career Highlights
Uta Behrends has worked with notable organizations that emphasize health and scientific research. She has been associated with Helmholtz Zentrum München – Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) and Deutsches Krebsforschungszentrum (DKFZ). These institutions have provided her with an environment to nurture her innovative ideas and translate them into impactful inventions.
Collaborations
Throughout her career, Uta has collaborated with esteemed colleagues such as Josef Mautner and Dinesh Adhikary. These partnerships illustrate a blend of expertise that has likely contributed to the advancement and implementation of her innovative approaches in immunology.
Conclusion
Uta Behrends exemplifies the spirit of innovation within the scientific community. Her patents demonstrate her commitment to advancing medical science and improving therapeutic strategies for patients with specific immune challenges. Uta's work stands as a testament to the importance of research and collaboration in the pursuit of medical breakthroughs.